AI-generated summary
The authors randomized 40 adults undergoing Femto-LASIK to periocular low-level light therapy at 633 nm or sham treatment around surgery. They report that tear volume and dry eye symptom scores stayed stable in the treated group, while the control group worsened, with between-group differences at later follow-up. The authors describe the findings as suggestive and call for further confirmatory studies.
- Participants
- 40
- Who or what was studied
- Adult patients (mean age 34.58 years) undergoing femtosecond laser-assisted in situ keratomileusis (Femto-LASIK)
- Wavelengths
- 633 nm
- Limits stated in the abstract
- The abstract states that further studies are warranted to confirm clinical benefit, and it reports a relatively small sample of 40 eyes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dry eye, Sham, Control group, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.